Dossier
Paul O'Driscoll
Coverage of Paul O'Driscoll in the Nexus archive.
- Sun Pharma to Acquire US-Listed Organon in $12 Billion Deal
Sun Pharma is set to acquire US-listed Organon in a $12 billion deal. The transaction marks a significant expansion for Sun Pharma in the pharmaceutical sector.